期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
新型青光眼引流装置——Paul青光眼植入物在印度尼西亚人群中应用的早期经验
1
作者 Emma Rusmayani Viona Viona +5 位作者 Iwan Soebijantoro rini sulastiwaty Arini Safira Nurul Akbar Muhammad Yoserizal Zeiras Eka Djamal Widya Artini Wiyogo 《国际眼科杂志》 CAS 北大核心 2023年第10期1603-1608,共6页
目的:探究Paul青光眼植入物(PGI)在短期随访期间的安全性和有效性,分享新型房水引流装置在印度尼西亚人群中应用的首次经验。方法:回顾性分析2022-04/2022-12期间使用PGI植入物的患者21例22眼,随访至少2mo。主要结局指标为手术失败,定... 目的:探究Paul青光眼植入物(PGI)在短期随访期间的安全性和有效性,分享新型房水引流装置在印度尼西亚人群中应用的首次经验。方法:回顾性分析2022-04/2022-12期间使用PGI植入物的患者21例22眼,随访至少2mo。主要结局指标为手术失败,定义为眼压(IOP)超过21mmHg,或连续2次就诊较基线水平降低小于20%,需行其他青光眼手术或移除植入物。结果:纳入患者的随访时间为2-6mo,平均IOP降低52.27±22.94%(9-90)%,总体成功率为59%,有青光眼手术史和未接受过青光眼手术的患者手术完全成功率分别为50%和59%。并发症有复视(2例)、早期低眼压(1例)、前房积血(1例)及引流管暴露(2例)。结论:植入PGI的完全成功率为57%。未发生严重术后并发症,低眼压术后早期消退1例。 展开更多
关键词 保罗青光眼植入物 青光眼分流管 青光眼引流植入物 青光眼手术 印度尼西亚人
下载PDF
Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients:one year follow-up
2
作者 Sara Listyani Koentjoro Widya Artini +6 位作者 Iwan Soebijantoro Vira Wardhana Istiantoro Emma Rusmayani rini sulastiwaty Zeiras Eka Djamal Arini Safira Nurul Akbar Muhammad Yoserizal 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2020年第12期1908-1914,共7页
AIM:To compare surgical results of the Ahmed and Baerveldt implant procedures in glaucoma patients at 1 y follow-up at Jakarta Eye Center(JEC)Eye Hospitals.METHODS:This cohort retrospective study was conducted on glau... AIM:To compare surgical results of the Ahmed and Baerveldt implant procedures in glaucoma patients at 1 y follow-up at Jakarta Eye Center(JEC)Eye Hospitals.METHODS:This cohort retrospective study was conducted on glaucoma patients aged≥18 y who had undergone Ahmed and Baerveldt implant surgery.Intraocular pressure(IOP),visual acuity,glaucoma medication,success rate,early and late postoperative complications,and the number of resurgeries were analyzed.RESULTS:A total of 351 eyes in the Ahmed group and 94 eyes in the Baerveldt group were included in this study.At 1 y follow-up,the mean IOP was found to be significantly lower in the Baerveldt group(13±4.47 mm Hg)compared to the Ahmed group(15.02±5.73 mm Hg;P=0.025).Glaucoma medication was required in both the Ahmed and Baerveldt groups(58.92%vs 71.67%).Comparable success rate was found in both groups.The Ahmed group revealed a complete and qualified success of 86.82%,and failure of 13.17%.Similarly,the Baerveldt group showed complete and qualified success in 87.75%and failure in 12.25%cases.In the Ahmed group,11.97%early complications,26.06%late complications and 9.97%resurgeries were observed.In comparison,in the Baerveldt group,23.40%early complications,30.95%late complications and 11.70%resurgeries were observed.CONCLUSION:Both groups of glaucoma implants show significant IOP reduction,however,the Baerveldt implant group demonstrates greater IOP reduction with more failure rates and complications than the Ahmed implant group. 展开更多
关键词 Ahmed implant Baerveldt implant intraocular pressure success rate COMPLICATIONS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部